When Standard Therapy Is Not Enough: Invasive MSSA Bacteremia with Cavernous Sinus Thrombosis and Mycotic Aneurysm Requiring Salvage Beta-Lactam Therapy
Private Practice Infectious Disease · 30.06.2026 · 6 (2)
DOI: 10.55636/ppid06020005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Private Practice Infectious Disease, online erschienen am 30.06.2026. Verfasst von Alice Han und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia is commonly treated with beta-lactam antibiotics, including cefazolin and antistaphylococcal penicillins. Although cefazolin is supported as first-line therapy for MSSA bacteremia, management of high-inoculum endovascular infections remains challenging, and persistent bacteremia may occur despite apparent susceptibility. We describe a 24-year-old man with a history of recurrent skin boils who presented with progressive facial swelling and high-grade MSSA bacteremia complicated by cavernous sinus thrombosis, septic venous thrombophlebitis, septic pulmonary emboli, and subsequent mycotic aneurysm with subarachnoid hemorrhage. Blood cultures remained persistently positive despite cefazolin monotherapy, raising concern for a high-inoculum endovascular infection and a possible cefazolin inoculum effect. Escalation to cefazolin plus ertapenem was associated with clearance of bacteremia, and the patient ultimately completed a prolonged course of cefazolin with clinical improvement after neurovascular intervention. This case highlights the limitations of cefazolin monotherapy in severe MSSA infections involving protected endovascular sites. In addition to aggressive diagnostic evaluation and source control, consideration of antimicrobial pharmacodynamics and the use of synergistic beta-lactam therapy may be warranted in refractory cases.
Zitieren
APA
Han, A., & Sidhwa, K. (2026). When Standard Therapy Is Not Enough: Invasive MSSA Bacteremia with Cavernous Sinus Thrombosis and Mycotic Aneurysm Requiring Salvage Beta-Lactam Therapy. Private Practice Infectious Disease, 6(2). https://doi.org/10.55636/ppid06020005
Vancouver
Han A, Sidhwa K. When Standard Therapy Is Not Enough: Invasive MSSA Bacteremia with Cavernous Sinus Thrombosis and Mycotic Aneurysm Requiring Salvage Beta-Lactam Therapy. Private Practice Infectious Disease. 2026;6(2). doi:10.55636/ppid06020005
BibTeX
@article{Han2026,
author = {Han, Alice and Sidhwa, Kamo},
title = {When Standard Therapy Is Not Enough: Invasive MSSA Bacteremia with Cavernous Sinus Thrombosis and Mycotic Aneurysm Requiring Salvage Beta-Lactam Therapy},
journal = {Private Practice Infectious Disease},
year = {2026},
volume = {6},
number = {2},
doi = {10.55636/ppid06020005}
}
EUVIMED